{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:48:40Z","timestamp":1787032120948,"version":"build-2736575974"},"reference-count":49,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IRDR"],"published-print":{"date-parts":[[2017]]},"DOI":"10.5582\/irdr.2017.01024","type":"journal-article","created":{"date-parts":[[2017,5,21]],"date-time":"2017-05-21T18:12:29Z","timestamp":1495390349000},"page":"95-101","source":"Crossref","is-referenced-by-count":38,"title":["Heart transplantation in patients with dystrophinopathic cardiomyopathy: Review of the literature and personal series"],"prefix":"10.5582","volume":"6","author":[{"given":"Andrea Antonio","family":"Papa","sequence":"first","affiliation":[{"name":"Cardiomyology and Medical Genetics, Department of Experimental Medicine, University of Campania \"Luigi Vanvitelli\""}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"D'Ambrosio","sequence":"additional","affiliation":[{"name":"Cardiomyology and Medical Genetics, Department of Experimental Medicine, University of Campania \"Luigi Vanvitelli\""}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Petillo","sequence":"additional","affiliation":[{"name":"Cardiomyology and Medical Genetics, Department of Experimental Medicine, University of Campania \"Luigi Vanvitelli\""}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Palladino","sequence":"additional","affiliation":[{"name":"Cardiomyology and Medical Genetics, Department of Experimental Medicine, University of Campania \"Luigi Vanvitelli\""}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Politano","sequence":"additional","affiliation":[{"name":"Cardiomyology and Medical Genetics, Department of Experimental Medicine, University of Campania \"Luigi Vanvitelli\""}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: One gene, several proteins, multiple phenotypes. Lancet Neurol. 2003; 2:731-740.","DOI":"10.1016\/S1474-4422(03)00585-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sadoulet-Puccio HM, Kunkel LM. Dystrophin and its isoforms. Brain Pathol. 1996; 6:25-35.","DOI":"10.1111\/j.1750-3639.1996.tb00780.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nigro G, Politano L, Nigro V, Petretta VR, Comi LI. Mutation of dystrophin gene and cardiomyopathy. Neuromuscul Disord. 1994; 4:371-379.","DOI":"10.1016\/0960-8966(94)90073-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Rafael JA, Cox GA, Corrado K, Jung D, Campbell KP, Chamberlain JS. Forced expression of dystrophin deletion constructs reveals structure-function correlations. J Cell Biol. 1996; 134:93-102.","DOI":"10.1083\/jcb.134.1.93"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Corrado K, Rafael JA, Mills PL, Cole NM, Faulkner JA, Wang K, Chamberlain JS. Transgenic mdx mice expressing dystrophin with a deletion in the actin-binding domain display a &quot;mild Becker&quot; phenotype. J Cell Biol. 1996; 134:873-884.","DOI":"10.1083\/jcb.134.4.873"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A. 1993; 90:3710-3714.","DOI":"10.1073\/pnas.90.8.3710"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wallace GQ, McNally EM. Mechanisms of muscle degeneration, regeneration and repair in the muscular dystrophies. Annu Rev Physiol. 2009; 71:37-57.","DOI":"10.1146\/annurev.physiol.010908.163216"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Obler D, Wu BL, Lip V, Estrella E, Keck S, Haggan C, Semigran M, Smoot LB. Familial dilated cardiomyopathy secondary to dystrophin splice site mutation. J Card Fail. 2010; 16:194-199.","DOI":"10.1016\/j.cardfail.2009.11.009"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Emery AE. Population frequencies of inherited neuromuscular diseases. A world survey. Neuromuscul Disord. 1991; 1:19-29.","DOI":"10.1016\/0960-8966(91)90039-U"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nigro G, Comi LI, Politano L, Bain RJ. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol. 1990; 26:271-277.","DOI":"10.1016\/0167-5273(90)90082-G"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Politano L, Nigro G. Managing dystrophinopathic cardiomyopathy. Expert Opin Orphan Drugs. 2016; 4:1159-1178.","DOI":"10.1080\/21678707.2016.1234373"},{"key":"12","unstructured":"12. Passamano L, Taglia A, Palladino A, Viggiano E, D&apos;Ambrosio P, Scutifero M, Rosaria Cecio M, Torre V, DE Luca F, Picillo E, Paciello O, Piluso G, Nigro G, Politano L. Improvement of survival in Duchenne muscular dystrophy: Retrospective analysis of 835 patients. Acta Myol. 2012; 31:121-125."},{"key":"13","unstructured":"13. Politano L, Nigro G. Treatment of dystrophinopathic cardiomyopathy: Review of the literature and personal results. Acta Myol. 2012; 31:24-30."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, Smith EO, Towbin JA. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation. 2005; 112:2799-2804.","DOI":"10.1161\/CIRCULATIONAHA.104.528281"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nigro G, Comi LI, Politano L, Nigro V. Dilated cardiomyopathy of muscular dystrophy: A multifaceted approach to management. Semin Neurol. 1995; 15:90-92.","DOI":"10.1055\/s-2008-1041012"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cohn RD, Campbell KP. Molecular pathways for dilated cardiomyopathy. In: Molecular basis of cardiovascular disease: A companion to Braunwald&apos;s heart disease (Chien K, editor). 2nd ed. Saunders Philadelphia, USA, 2004; pp. 306-310.","DOI":"10.1016\/B978-0-7216-9428-3.50022-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Towbin JA, Hejtmancik JF, Brink P, Gelb B, Zhu XM, Chamberlain JS, McCabe ER, Swift M. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation. 1993; 87:1854-1865.","DOI":"10.1161\/01.CIR.87.6.1854"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Spurney CF. Cardiomyopathy of Duchenne muscular dystrophy: Current understanding and future directions. Muscle Nerve. 2011; 44:8-19.","DOI":"10.1002\/mus.22097"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kaspar RW, Allen HD, Montanaro F. Current under-standing and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy. J Am Acad Nurse Pract. 2009; 21:241-249.","DOI":"10.1111\/j.1745-7599.2009.00404.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nigro G, Di Somma S, Comi LI, Politano L, Papparella S, Restucci B, Petretta VR, Giugliano MA, Carotenuto A, Limongelli FM, DE Divitiis O. Structural basis of cardiomyopathy in Duchenne\/Becker carriers. Endomyocardial biopsy evaluation. Ann N Y Acad Sci. 1995; 752:108-110.","DOI":"10.1111\/j.1749-6632.1995.tb17412.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Politano L, Nigro V, Nigro G, Petretta VR, Passamano L, Papparella S, Di Somma S, Comi LI. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA. 1996; 275:1335-1338.","DOI":"10.1001\/jama.1996.03530410049032"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Comi LI, Nigro G, Politano L, Petretta VR. The cardiomyopathy of Duchenne\/Becker consultands. Int J Cardiol. 1992; 34:297-305.","DOI":"10.1016\/0167-5273(92)90028-2"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Hoogerwaard EM, van der Wouw PA, Wilde AA, Bakker E, Ippel PF, Oosterwijk JC, Majoor-Krakauer DF, van Essen AJ, Leschot NJ, de Visser M. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 1999; 9:347-351.","DOI":"10.1016\/S0960-8966(99)00018-8"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kamakura K, Kawai M, Arahata K, Koizumi H, Watanabe K, Sugita H. A manifesting carrier of Duchenne muscular dystrophy with severe myocardial symptoms. J Neurol. 1990; 237:483-485.","DOI":"10.1007\/BF00314767"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Mirabella M, Servidei S, Manfredi G, Ricci E, Frustaci A, Bertini E, Rana M, Tonali P. Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy. Neurology. 1993; 43:2342-2345.","DOI":"10.1212\/WNL.43.11.2342"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Viggiano E, Picillo E, Cirillo A, Politano L. Comparison of X-chromosome inactivation in Duchenne muscle\/myocardium-manifesting carriers, non-manifesting carriers and related daughters. Clin Genet. 2013; 84:265-270.","DOI":"10.1111\/cge.12048"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Viggiano E, Ergoli M, Picillo E, Politano L. Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy. Hum Genet. 2016; 135:685-698.","DOI":"10.1007\/s00439-016-1666-6"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Viggiano E, Picillo E, Ergoli M, Cirillo A, Del Gaudio S, Politano L. Skewed X-chromosome inactivation plays a crucial role in the onset of symptoms in carriers of Becker muscular dystrophy. J Gene Med. 2017; doi: 10.1002\/jgm.2952.","DOI":"10.1002\/jgm.2952"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Finsterer J, St\u00f6llberger C. The heart in human dystrophinopathies. Cardiology. 2003; 99:1-19.","DOI":"10.1159\/000068446"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Michele DE, Campbell KP. Cardiomyopathy in muscular dystrophies. In: Molecular mechanisms of cardiac hypertrophy and failure (Walsh RA, editor). Taylor &amp; Francis, London, UK, 2005; pp.541-567.","DOI":"10.3109\/9780203503249-37"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Cripe L, Kinnett K, Uzark K, Eghtesady P, Wong B, Spicer R. P1.14 Cardiac transplantation in Duchenne muscular dystrophy: A case report. Neuromuscul Disord. 2011; 21:645. Doi:10.1016\/j.nmd.2011.06.774","DOI":"10.1016\/j.nmd.2011.06.774"},{"key":"32","unstructured":"32. Rees W, Sch\u00fcler S, Hummel M, Hetzer R. Heart transplantation in patients with muscular dystrophy associated with end-stage cardiomyopathy. J Heart Lung Transplant. 1993; 12:804-807."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Amodeo A, Adorisio R. Left ventricular assist device in Duchenne cardiomyopathy: Can we change the natural history of cardiac disease? Int J Cardiol. 2012; 29:161:e43.","DOI":"10.1016\/j.ijcard.2012.04.009"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Wu RS, Gupta S, Brown RN, Yancy CW, Wald JW, Kaiser P, Kirklin NM, Patel PC, Markham DW, Drazner MH, Garry DJ, Mammen PP. Clinical outcomes after cardiac transplantation in muscular dystrophy patients. J Heart Lung Transplant. 2010; 29:432-438.","DOI":"10.1016\/j.healun.2009.08.030"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Ruiz-Cano MJ, Delgado JF, Jim\u00e9nez C, Jim\u00e9nez S, Cea-Calvo L, S\u00e1nchez V, Escribano P, G\u00f3mez MA, Gil-Fraguas L, S\u00e1enz de la Calzada C. Successful heart transplantation in patients with inherited myopathies associated with end-stage cardiomyopathy. Transplant Proc. 2003; 35:1513-1515.","DOI":"10.1016\/S0041-1345(03)00515-3"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Casazza F, Brambilla G, Salvato A, Morandi L, Gronda E, Bonacina E. Cardiac transplantation in Becker muscular dystrophy. J Neurol. 1988; 235:496-498.","DOI":"10.1007\/BF00314256"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Patan\u00e8 F, Zingarelli E, Attisani M, Sansone F. Successful heart transplantation in Becker&apos;s muscular dystrophy. Eur J Cardiothorac Surg. 2006; 29:250.","DOI":"10.1016\/j.ejcts.2005.11.012"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Melacini P, Gambino A, Caforio A, Barchitta A, Valente ML, Angelini A, Fanin M, Thiene G, Angelini C, Casarotto D, Danieli GA, Dalla-Volta S. Heart transplantation in patients with inherited myopathies associated with end-stage cardiomyopathy: Molecular and biochemical defects on cardiac and skeletal muscle. Transplant Proc. 2001; 33:1596-1599.","DOI":"10.1016\/S0041-1345(00)02607-5"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Steger CM, H\u00f6fer D, Antretter H. Cardiac manifestation in muscular dystrophies leading to heart transplantation. European Surgery. 2013; 45:245-250.","DOI":"10.1007\/s10353-013-0195-y"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Yilmaz A, Gdynia HJ, Baccouche H, Mahrholdt H, Meinhardt G, Basso C, Thiene G, Sperfeld AD, Ludolph AC, Sechtem U. Cardiac involvement in patients with Becker muscular dystrophy: New diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson. 2008; 10:50.","DOI":"10.1186\/1532-429X-10-50"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Nigro G, Comi LI, Politano L, et al. Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle Nerve. 1995; 18:283-291.","DOI":"10.1002\/mus.880180304"},{"key":"42","unstructured":"42. Politano L, Palladino A, Nigro G, Scutifero M, Cozza V. Usefulness of heart rate variability as a predictor of sudden cardiac death in muscular dystrophies. Acta Myol. 2008 ;27:114-122."},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Ducceschi V, Nigro G, Sarubbi B, Comi LI, Politano L, Petretta VR, Nardi S, Briglia N, Santangelo L, Nigro G, Iacono A. Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy. Int J Cardiol. 1997 May 23;59:275-279.","DOI":"10.1016\/S0167-5273(97)02933-1"},{"key":"44","unstructured":"44. Fayssoil A, Abasse S. Cardiac resynchronization therapy in Becker muscular dystrophy: For which patients? Hellenic J Cardiol. 2010; 51:377-378."},{"key":"45","unstructured":"45. Grande AM, Rinaldi M, Pasquino S, D&apos;Armini AM, Vigan\u00f2 M. Heart transplantation in X-linked dilated cardiomyopathy. Ital Heart J. 2002; 3:476-478."},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Diegoli M, Grasso M, Favalli V, Serio A, Gambarin FI, Klersy C, Pasotti M, Agozzino E, Scelsi L, Ferlini A, Febo O, Piccolo G, Tavazzi L, Narula J, Arbustini E. Diagnostic work-up and risk stratification in X-linked dilated cardiomyopathies caused by dystrophin defects. J Am Coll Cardiol. 2011; 58:925-934.","DOI":"10.1016\/j.jacc.2011.01.072"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Melacini P, Fanin M, Angelini A, Pegoraro E, Livi U, Danieli GA, Hoffman EP, Thiene G, Dalla Volta S, Angelini C. Cardiac transplantation in a Duchenne muscular dystrophy carrier. Neuromuscul Disord. 1998; 8:585-590.","DOI":"10.1016\/S0960-8966(98)00071-6"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Davies JE, Winokur TS, Aaron MF, Benza RL, Foley BA, Holman WL. Cardiomyopathy in a carrier of Duchenne&apos;s muscular dystrophy. J Heart Lung Transplant. 2001; 20:781-784.","DOI":"10.1016\/S1053-2498(00)00240-0"},{"key":"49","unstructured":"49. Ketelsen UP, Trenk D, Eschenbruch EM, Tollenaere PJ. Myopathy\/rhabdomyolisis in patients after heart transplantation by presurgical treatment with lipid-lowering drugs? Interaction of cyclosporine and HMG-CoA reductase inhibitor therapy? Neuromuscul Disord.1997; 7:446."}],"container-title":["Intractable &amp; Rare Diseases Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/6\/2\/6_2017.01024\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T18:22:39Z","timestamp":1569349359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/irdr\/6\/2\/6_2017.01024\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.5582\/irdr.2017.01024","relation":{},"ISSN":["2186-361X","2186-3644"],"issn-type":[{"value":"2186-361X","type":"electronic"},{"value":"2186-3644","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}